Large Cryptocurrencies Mixed As Ripple Falls
This article was automatically generated by MarketWatch using technology from Automated Insights.
Large cryptocurrencies were mixed during morning trading on Tuesday, with Ripple seeing the biggest move, falling 2.30% to 64 cents.
Solana lead the increases with a 0.48% climb to $192.87.
Five other currencies posted drops Tuesday. Bitcoin inched down 0.77% to $70,392.70, and Ethereum sank 0.54% to $3,608.94.
Polygon slid 0.35% to $1.05, and Polkadot slipped 9.81% to $9.81.
Cardano recorded the smallest decline, tumbling 0.04% to 67 cents.
In addition to Solana, two other cryptocurrencies saw increases. Dogecoin climbed 0.36% to 18 cents, and Uniswap climbed 0.33% to $12.61.
In crypto-related company news, shares of Coinbase Global Inc. inched down 0.59% to $278.07, while MicroStrategy Inc. climbed 0.49% to $1,865.01. Riot Platforms Inc. shares fell 2.25% to $12.16, and shares of Marathon Digital Holdings Inc. dropped 3.10% to $20.30.
Block Inc. rose 2.51% to $84.69 and Tesla Inc. rose 5.38% to $181.91.
PayPal Holdings Inc. rose 1.30% to $66.86, and Ebang International Holdings Inc. shares climbed 1.77% to $9.20. NVIDIA Corp. climbed 0.56% to $955.33, and Advanced Micro Devices Inc. slipped 0.45% to $177.82.
In the fund space, blockchain-focused Amplify Transformational Data Sharing ETF slipped 0.44% to $36.15. The Bitwise Crypto Industry Innovators ETF, which is focused on pure-play crypto companies, slipped 0.94% to $13.18.
Data source: Dow Jones Market Data, FactSet.
(END) Dow Jones Newswires
March 26, 2024 10:15 ET (14:15 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Markets Brief: AI Leaders Excel in Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth